Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STD Pharmaceutical Products is a specialized UK-based pharmaceutical company that focuses on the development and manufacture of sclerosing agents for the treatment of venous disorders. The company is best known for its flagship product, Fibrovein (sodium tetradecyl sulfate), which is a leading detergent-type sclerosant used globally for varicose veins and telangiectasias. Operating through its manufacturing arm, STD Manufacturing Ltd, the firm maintains high-standard GMP facilities to produce sterile injectable solutions. With a history spanning over five decades, the company has established itself as a key player in the field of phlebology, providing essential treatments for vascular conditions. The company's name "STD" is derived from its core active ingredient, Sodium Tetradecyl.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STD Manufacturing.